Pyc Therapeutics Ltd has released a press release.
CEO Update
Filed with ASX ·
On 6ix: 6ix.com/news/ceo-update-9
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- March 2018 Operational Update and Cashflow
- Changes to Board and Management
- Cre Enzyme Delivery Provides Validation & Strategic Value
- Dec 2017 Half-year financial statements & Appendix 4D
- Dec Quarterly Update and Appendix 4C
Later from PYC Therapeutics
- Successful In-vivo Results Peptide Vaccine T-Cell Expansion
- Achievement of Major Milestone - In vivo Cre Delivery
- June 2018 Quarterly Operational Update and App4C
- Update on Capital Raising
- Suspension from Official Quotation
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics